Cargando…

Management and prognosis of pancreatic cancer over a 30-year period

BACKGROUND: The aim of this study was to report on changes in the diagnostic assessment, patterns of care and survival over time for pancreatic cancers. METHODS: A total of 2986 cases of pancreatic cancer from the Digestive Cancer Registry of Burgundy (France) over a 30-year period (1976–2005) were...

Descripción completa

Detalles Bibliográficos
Autores principales: David, M, Lepage, C, Jouve, J-L, Jooste, V, Chauvenet, M, Faivre, J, Bouvier, A-M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720200/
https://www.ncbi.nlm.nih.gov/pubmed/19568238
http://dx.doi.org/10.1038/sj.bjc.6605150
_version_ 1782170114740715520
author David, M
Lepage, C
Jouve, J-L
Jooste, V
Chauvenet, M
Faivre, J
Bouvier, A-M
author_facet David, M
Lepage, C
Jouve, J-L
Jooste, V
Chauvenet, M
Faivre, J
Bouvier, A-M
author_sort David, M
collection PubMed
description BACKGROUND: The aim of this study was to report on changes in the diagnostic assessment, patterns of care and survival over time for pancreatic cancers. METHODS: A total of 2986 cases of pancreatic cancer from the Digestive Cancer Registry of Burgundy (France) over a 30-year period (1976–2005) were considered. Non-conditional logistic regressions were carried out to identify the factors associated with resection for cure and with the use of chemotherapy. A multivariate relative survival analysis was carried out. RESULTS: Diagnostic procedures have changed. Ultrasonography and computed tomography progressively have become the major diagnostic procedures. There was a slight improvement in stage: the proportion of stage I–II was 2.8% in the 1976–1980 period and 8.8% in the 2001–2005 period (P<0.001). There was a similar trend in the proportion of cases resected for cure, the corresponding percentages being 4.5 and 11.3%, respectively (P<0.001). The 5-year relative survival increased from 2.0 to 4.2% (P<0.001). In the multivariate relative survival analysis, the period remained a significant prognostic factor. Stage, sex, age and histology were independent prognostic factors. CONCLUSION: Over a 30-year period, there were minor changes in the stage at diagnosis, resection for cure and prognosis of pancreatic cancers, although there were improvements in the diagnostic modalities. Pancreatic cancer still represents a major challenge in oncology.
format Text
id pubmed-2720200
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-27202002010-07-21 Management and prognosis of pancreatic cancer over a 30-year period David, M Lepage, C Jouve, J-L Jooste, V Chauvenet, M Faivre, J Bouvier, A-M Br J Cancer Clinical Study BACKGROUND: The aim of this study was to report on changes in the diagnostic assessment, patterns of care and survival over time for pancreatic cancers. METHODS: A total of 2986 cases of pancreatic cancer from the Digestive Cancer Registry of Burgundy (France) over a 30-year period (1976–2005) were considered. Non-conditional logistic regressions were carried out to identify the factors associated with resection for cure and with the use of chemotherapy. A multivariate relative survival analysis was carried out. RESULTS: Diagnostic procedures have changed. Ultrasonography and computed tomography progressively have become the major diagnostic procedures. There was a slight improvement in stage: the proportion of stage I–II was 2.8% in the 1976–1980 period and 8.8% in the 2001–2005 period (P<0.001). There was a similar trend in the proportion of cases resected for cure, the corresponding percentages being 4.5 and 11.3%, respectively (P<0.001). The 5-year relative survival increased from 2.0 to 4.2% (P<0.001). In the multivariate relative survival analysis, the period remained a significant prognostic factor. Stage, sex, age and histology were independent prognostic factors. CONCLUSION: Over a 30-year period, there were minor changes in the stage at diagnosis, resection for cure and prognosis of pancreatic cancers, although there were improvements in the diagnostic modalities. Pancreatic cancer still represents a major challenge in oncology. Nature Publishing Group 2009-07-21 2009-06-30 /pmc/articles/PMC2720200/ /pubmed/19568238 http://dx.doi.org/10.1038/sj.bjc.6605150 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Study
David, M
Lepage, C
Jouve, J-L
Jooste, V
Chauvenet, M
Faivre, J
Bouvier, A-M
Management and prognosis of pancreatic cancer over a 30-year period
title Management and prognosis of pancreatic cancer over a 30-year period
title_full Management and prognosis of pancreatic cancer over a 30-year period
title_fullStr Management and prognosis of pancreatic cancer over a 30-year period
title_full_unstemmed Management and prognosis of pancreatic cancer over a 30-year period
title_short Management and prognosis of pancreatic cancer over a 30-year period
title_sort management and prognosis of pancreatic cancer over a 30-year period
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720200/
https://www.ncbi.nlm.nih.gov/pubmed/19568238
http://dx.doi.org/10.1038/sj.bjc.6605150
work_keys_str_mv AT davidm managementandprognosisofpancreaticcancerovera30yearperiod
AT lepagec managementandprognosisofpancreaticcancerovera30yearperiod
AT jouvejl managementandprognosisofpancreaticcancerovera30yearperiod
AT joostev managementandprognosisofpancreaticcancerovera30yearperiod
AT chauvenetm managementandprognosisofpancreaticcancerovera30yearperiod
AT faivrej managementandprognosisofpancreaticcancerovera30yearperiod
AT bouvieram managementandprognosisofpancreaticcancerovera30yearperiod